Researchers monitored changes in body mass index (BMI), weight, flare frequency, Dermatology Life Quality Index (DLQI) value, and pain levels before and after starting semaglutide, as well as biochemical markers, including C-reactive protein (CRP), glucose, and hemoglobin A1c (HbA1c) levels
His work has been cited in more than 45 published medical journal articles and has been referenced by the CDC, FDA, The New York Times, and numerous state and local health departments
Healthcare providers emphasize the importance of regular monitoring and communication
Others report that niacinamide in tirzepatide reduces the flushing some people experience
To qualify, patients must: Be 18 years or older, non-pregnant Have a Body Mass Index (BMI) of 30 kg/m, or Have a BMI of 25 kg/m with at least one obesity-related risk factor (e.g., hypertension, diabetes) While semaglutide is an effective weight management tool, it is not for everyone
While semaglutide has minimal direct pharmacokinetic interactions, its effects on gastric emptying and blood sugar control can influence how other medications work in your body